3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Burkitt Lymphoma
1
Anus Neoplasms
1
Interventions
Oxaliplatin
17
Leucovorin
13
Fluorouracil
13
Cetuximab
12
Bevacizumab
10
pembrolizumab
7
Specimen Handling
7
Nivolumab
7
Magnetic Resonance Spectroscopy
6
Irinotecan
6
Capecitabine
6
encorafenib
4
Pemetrexed
4
Gemcitabine
4
Cisplatin
4
fludarabine
3
cemiplimab
3
Laparoscopy
3
Folfox protocol
3
Early Intervention, Educational
3
Cyclophosphamide
3
Celecoxib
3
Carboplatin
3
Biopsy
3
trifluridine tipiracil drug combination
2
relatlimab
2
pertuzumab
2
palbociclib
2
durvalumab
2
dehydroftorafur
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Colonic Neoplasms
×
Diphenhydramine
×
90 days
×
Clear all
No trials found.